Cargando…
Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?
Mesenchymal stromal cells (MSCs) are under active consideration as a treatment strategy for controlling the hyper-inflammation and slow disease progression associated with coronavirus disease 2019 (COVID-19). The possible mechanism of protection through their immunoregulatory and paracrine action ha...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084615/ https://www.ncbi.nlm.nih.gov/pubmed/34053857 http://dx.doi.org/10.1016/j.jcyt.2021.04.004 |